TOMSK, RUSSIA / RankWire.AI / – Russian scientists have explored a bioactive surface layer aimed at enhancing the integration of titanium orthopedic implants with bone tissue. This innovative coating incorporates calcium phosphate derived from hydroxyapatite and contains nitrogen compounds linked to nitric oxide synthesis. Laboratory investigations demonstrated a notable increase in the survival rate of human mesenchymal stem cells on the coated surfaces compared to uncoated titanium. The research team analyzed the coating’s structure, chemical makeup, mechanical qualities, and biological effects. Their peer-reviewed results appeared in Applied Surface Science in 2026.
At Tomsk Polytechnic University, scientists manufactured these experimental coatings using reactive magnetron sputtering of a hydroxyapatite target inside a vacuum chamber. They adjusted the nitrogen-to-argon ratio during deposition to study how each mixture influenced the final surface properties. The study examined five different conditions, ranging from pure nitrogen to pure argon. The team then measured parameters such as coating thickness, surface morphology, hardness, wettability, and chemical composition. They also performed laboratory tests to evaluate cellular responses to the modified titanium surfaces.
Results indicated that the argon content significantly influenced several physical characteristics of the coatings. Surfaces created in pure argon proved denser and harder than those formed in pure nitrogen. Additionally, coating thickness increased with higher argon levels. Chemical analysis revealed the presence of nitrogen-carbon and nitrogen-oxygen bonds on the modified surfaces. When comparing human mesenchymal stem cells grown on coated titanium to those on uncoated samples, the biological assessments focused on cell viability and markers associated with osteogenic differentiation.
Enhanced Cell Survival Observed in Coating Tests
The experiments demonstrated that cells exhibited significantly higher survival rates on coated surfaces than on uncoated titanium, according to the study findings. After seven days, coatings with increased nitrogen content also appeared to suppress the activity of certain genes linked to early bone-cell differentiation. Despite this, the stem cells maintained their ability to form bone tissue. These tests were carried out under controlled laboratory conditions using human mesenchymal stem cells, and the study did not involve clinical trials or the assessment of actual medical implants in patients.
The biomedical evaluation was conducted by researchers from Immanuel Kant Baltic Federal University and Siberian State Medical University. The wider research team also included specialists from Saint Petersburg State University. The project received backing through Russia’s national science program. Focus was placed on identifying gas mixtures capable of producing coatings with advantageous physical, chemical, and biological features. Hydroxyapatite is already used in implant coatings because its calcium phosphate composition resembles the mineral component of human bone.
The Study Is Still in the Laboratory Phase
The researchers have outlined plans for further testing beyond the initial seven-day cell viability experiments. They aim to observe stem cell behavior over periods ranging from 10 to 28 days, as well as study the dissolution rate of the coatings and the release of nitric oxide into surrounding tissue in vivo. These subsequent investigations were not included in the published laboratory data. Currently, the study focuses on coated titanium substrates, their material properties, and in vitro cellular responses, rather than clinical performance or outcomes in orthopaedic patients.
The data obtained provide detailed insights into how varying ratios of nitrogen and argon influence calcium phosphate coatings on titanium surfaces. The study documented differences in coating thickness, density, hardness, chemical bonds, and cellular responses based on the gas mixture used. Importantly, the results showed that coated samples supported higher stem-cell survival compared to uncoated titanium under laboratory conditions. However, as a preclinical study, it does not establish safety or efficacy for use in humans, and further biological evaluations will be necessary to explore properties not addressed in this work.